Subscribe to RSS
Download PDF
DOI: 10.1055/s-0038-1636465
On a Vaccination Model for Non-fatal Rare Infectious Diseases; with Emphasis on Rubella in Kuwait
ÜBER EIN IMPFMODELL FÜR NICHTTÖDLICHE, SELTENE INFEKTIONSKRANKHEITEN; MIT BETONUNG AUF RÖTELN IN KUWAITPublication History
Publication Date:
14 February 2018 (online)
An immunization model for non-fatal rare contagious diseases in non-fixed size communities (developing countries) is proposed. It reveals the demographic and epidemiological data needed in a country to decide upon the best strategy of vaccination. The approach is illustrated with reference to rubella in Kuwait population. Comparisons between rubella vaccination strategies of the U.S.A., U.K. and a recently suggested one for Kuwait are carried out.
Ein Imnnmisationsmodell für nichttödhche, seltene ansteckende Krankheiten in Gemeinden von nicht fixierter Größe (Entwicklungsländer) wird vorgeschlagen. Es zeigt die demographischen und epidemiologischen Daten auf, die erforderlich sind, um die für ein Land beste Impfstrategie festzulegen. Die Methode wird an einem Beispiel von Röteln an der Bevölkerung von Kuwait illustriert. Vergleiche zwischen Impfungsstrategien gegen Röteln in den USA, Großbritannien und einer kürzlich für Kuwait vorgeschlagenen Strategie werden durchgeführt.
-
References
- 1 Annual Statistical Abstract. Central Statistical Office, Edition XIV. ( Ministry of Planning; Kuwait: 1977. .).
- 2 BECKER N.. Vaccination Programmes for Rare Infectious Diseases. Biometrika 59 ( 1972; ) 443-453.
- 3 Center for Disease Control: Rubella Surveillance. January 1972 to July 1973. November 1973
- 4 CHANG T. W., DESROSIERS S., WEINSTEIN L.. Clinical and Serologic Studies of an Outbreak of Rubella in a Vaccinated Population. New Engl. J. Med 283 ( 1970; ) 246-248.
- 5 EVANS A. S.. (Edit.) Viral Infections of Humans — Epidemiology and Control. ( Plenum Medical Book Company; New York and London: 1976. .).
- 6 HARDY J. B., MCCRACKEN G. H., GIIKESON M. R., SEVER J. L.. Adverse Fetal Outcome Following Maternal Rubella after the First Trimester of Pregnancy. J. Amer. ined. Ass 207 ( 1969; ) 2414-2420.
- 7 HATHOTJT H., AL-NAKEB W., LILEY H., ABO-AHMAD H. S., NOSSEIR A. F.. Seroepidemiology of Rubella in Kuwait: An Alternative Vaccination Policy. Int. J. Epidemiol 7 ( 1978; ) 49-83.
- 8 HORSTMANN D. M., BANATVALA J. E., RIORDAN J. T., PAYNE M. C., WHITTEMORE R., OPTON E. M., FLOREY C.. Maternal Rubella and the Rubella Syndrome in Infants. Amer. J. Dis. Child 110 ( 1965; ) 408-415.
- 9 HORSTMANN D. M., LIEBHABER H., LEBOTJVIER G. L., ROSENBERG D. A., HALSTEAD S. B.. Rubella-Reinfection of Vaccinated and Naturally Immune Persons Exposed in an Epidemic. New Engl. J. Med 283 ( 1970; ) 771-778.
- 10 JACKSON A. D. M.. Deafness Following Maternal Rubella — Results of a Prospective Investigation. Lancet 1958; II: 1241-1244.
- 11 KLOCK L. E., RACHELEPSKY G. S.. Failure of Rubella Herd Immunity during an Epidemic. New Engl. J. Med 2SS ( 1973; ) 69-69.
- 12 LDNDSTRÖ M. R.. Rubella during Pregnancy — A Follow-up Study of Children Born after an Epidemic of Rubella in Sweden, 1951. With Additional Investigations on Prophylaxis and Treatment of Maternal Rubella. Acta paediat. scand. 51, Suppl 133 ( 1962; ) 1-88.
- 13 OGRA P. L., HERD J. K.. Arthritis Associated with Induced Rubella Infection. J. Immunol 107 ( 1971; ) 810-813.
- 14 BAWLS W. E., MELNICK J. L., BRADSTREET C. M. P.. WHO Collaborative Study on Seroepidemiology of Rubella. Bull. WHO. 37. ( 1967 ) 79.
- 15 WEIBEL R. E., STOKES J., BUYNAK E. B., HEILLEMAN M. R.. Influence of Age on Clinical Response to HPV77 Duck Rubella Vaccine. J. Amer. med. Ass 222 ( 1972; ) 805-807.